Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 776 entries
Sorted by: Best Match Show Resources per page
Ellagic acid alleviates adjuvant induced arthritis by modulation of pro- and anti-inflammatory cytokines.

Central-European journal of immunology

Allam G, Mahdi EA, Alzahrani AM, Abuelsaad AS.
PMID: 28450796
Cent Eur J Immunol. 2016;41(4):339-349. doi: 10.5114/ceji.2016.65132. Epub 2017 Jan 24.

Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown aetiology, but it is now clear that pro-inflammatory cytokines play a central role in its pathogenesis. Ellagic acid (EA) has a variety of biological activities including anti-oxidant, anti-inflammatory, and...

Cite
Allam G, Mahdi EA, Alzahrani AM, et al. Ellagic acid alleviates adjuvant induced arthritis by modulation of pro- and anti-inflammatory cytokines. Cent Eur J Immunol. 2017;41(4):339-349doi: 10.5114/ceji.2016.65132.
Allam, G., Mahdi, E. A., Alzahrani, A. M., & Abuelsaad, A. S. (2016). Ellagic acid alleviates adjuvant induced arthritis by modulation of pro- and anti-inflammatory cytokines. Central-European journal of immunology, 41(4), 339-349. https://doi.org/10.5114/ceji.2016.65132
Allam, Gamal, et al. "Ellagic acid alleviates adjuvant induced arthritis by modulation of pro- and anti-inflammatory cytokines." Central-European journal of immunology vol. 41,4 (2016): 339-349. doi: https://doi.org/10.5114/ceji.2016.65132
Allam G, Mahdi EA, Alzahrani AM, Abuelsaad AS. Ellagic acid alleviates adjuvant induced arthritis by modulation of pro- and anti-inflammatory cytokines. Cent Eur J Immunol. 2016;41(4):339-349. doi: 10.5114/ceji.2016.65132. Epub 2017 Jan 24. PMID: 28450796; PMCID: PMC5382880.
Copy Download .nbib Format: NLM
Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer.

Central-European journal of immunology

Słotwiński R, Słotwińska SM.
PMID: 28450803
Cent Eur J Immunol. 2016;41(4):392-403. doi: 10.5114/ceji.2016.65139. Epub 2017 Jan 24.

Pancreatic cancer occupies the fourth place as a cause of death from cancer, and the mortality rate is similar to the number of newly detected cases. Due to the late diagnosis, only 5-6% of patients with pancreatic cancer survive...

Cite
Słotwiński R, Słotwińska SM. Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer. Cent Eur J Immunol. 2017;41(4):392-403doi: 10.5114/ceji.2016.65139.
Słotwiński, R., & Słotwińska, S. M. (2016). Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer. Central-European journal of immunology, 41(4), 392-403. https://doi.org/10.5114/ceji.2016.65139
Słotwiński, Robert, and Słotwińska, Sylwia Małgorzata. "Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer." Central-European journal of immunology vol. 41,4 (2016): 392-403. doi: https://doi.org/10.5114/ceji.2016.65139
Słotwiński R, Słotwińska SM. Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer. Cent Eur J Immunol. 2016;41(4):392-403. doi: 10.5114/ceji.2016.65139. Epub 2017 Jan 24. PMID: 28450803; PMCID: PMC5382885.
Copy Download .nbib Format: NLM
MicroRNAs as regulators of drug abuse and immunity.

Central-European journal of immunology

Zhang K, Jing X, Wang G.
PMID: 28450806
Cent Eur J Immunol. 2016;41(4):426-434. doi: 10.5114/ceji.2016.65142. Epub 2017 Jan 24.

MicroRNAs (miRNAs) are 20-22 nucleotide non-coding RNAs that participate in gene regulation. They bind to 3'-untranslated regions of their mRNA targets, inhibiting the transcripts' translation and/or destabilizing them. Chronic drug abuse induces changes of miRNAs expression in the brain,...

Cite
Zhang K, Jing X, Wang G. MicroRNAs as regulators of drug abuse and immunity. Cent Eur J Immunol. 2017;41(4):426-434doi: 10.5114/ceji.2016.65142.
Zhang, K., Jing, X., & Wang, G. (2016). MicroRNAs as regulators of drug abuse and immunity. Central-European journal of immunology, 41(4), 426-434. https://doi.org/10.5114/ceji.2016.65142
Zhang, Kai, et al. "MicroRNAs as regulators of drug abuse and immunity." Central-European journal of immunology vol. 41,4 (2016): 426-434. doi: https://doi.org/10.5114/ceji.2016.65142
Zhang K, Jing X, Wang G. MicroRNAs as regulators of drug abuse and immunity. Cent Eur J Immunol. 2016;41(4):426-434. doi: 10.5114/ceji.2016.65142. Epub 2017 Jan 24. PMID: 28450806; PMCID: PMC5382888.
Copy Download .nbib Format: NLM
New human single chain anti-idiotypic antibody against benzo[a]pyrene.

Central-European journal of immunology

Studennikov AE, Ustinov VA, Morozova VV, Tikunova NV, Glushkov AN.
PMID: 28860930
Cent Eur J Immunol. 2017;42(2):123-130. doi: 10.5114/ceji.2017.69353. Epub 2017 Aug 08.

The nal¨ve library from the lymphocytes of healthy humans was screened by murine single-stranded idiotypic antibodies against benzo[a]pyrene (pSh). The phage clone which contained of anti-idiotypic antibody against benzo[a]pyrene, designated as A4, was chosen for further work because of...

Cite
Studennikov AE, Ustinov VA, Morozova VV, et al. New human single chain anti-idiotypic antibody against benzo[a]pyrene. Cent Eur J Immunol. 2017;42(2):123-130doi: 10.5114/ceji.2017.69353.
Studennikov, A. E., Ustinov, V. A., Morozova, V. V., Tikunova, N. V., & Glushkov, A. N. (2017). New human single chain anti-idiotypic antibody against benzo[a]pyrene. Central-European journal of immunology, 42(2), 123-130. https://doi.org/10.5114/ceji.2017.69353
Studennikov, Artem E, et al. "New human single chain anti-idiotypic antibody against benzo[a]pyrene." Central-European journal of immunology vol. 42,2 (2017): 123-130. doi: https://doi.org/10.5114/ceji.2017.69353
Studennikov AE, Ustinov VA, Morozova VV, Tikunova NV, Glushkov AN. New human single chain anti-idiotypic antibody against benzo[a]pyrene. Cent Eur J Immunol. 2017;42(2):123-130. doi: 10.5114/ceji.2017.69353. Epub 2017 Aug 08. PMID: 28860930; PMCID: PMC5573885.
Copy Download .nbib Format: NLM
Effect of dietary antioxidant supplementation (Cuminum cyminum) on bacterial susceptibility of diabetes-induced rats.

Central-European journal of immunology

Moubarz G, Embaby MA, Doleib NM, Taha MM.
PMID: 27536197
Cent Eur J Immunol. 2016;41(2):132-7. doi: 10.5114/ceji.2016.60985. Epub 2016 Jul 15.

Diabetic patients are at risk of acquiring infections. Chronic low-grade inflammation is an important factor in the pathogenesis of diabetic complication. Diabetes causes generation of reactive oxygen species that increases oxidative stress, which may play a role in the...

Cite
Moubarz G, Embaby MA, Doleib NM, et al. Effect of dietary antioxidant supplementation (Cuminum cyminum) on bacterial susceptibility of diabetes-induced rats. Cent Eur J Immunol. 2016;41(2):132-7doi: 10.5114/ceji.2016.60985.
Moubarz, G., Embaby, M. A., Doleib, N. M., & Taha, M. M. (2016). Effect of dietary antioxidant supplementation (Cuminum cyminum) on bacterial susceptibility of diabetes-induced rats. Central-European journal of immunology, 41(2), 132-7. https://doi.org/10.5114/ceji.2016.60985
Moubarz, Gehan, et al. "Effect of dietary antioxidant supplementation (Cuminum cyminum) on bacterial susceptibility of diabetes-induced rats." Central-European journal of immunology vol. 41,2 (2016): 132-7. doi: https://doi.org/10.5114/ceji.2016.60985
Moubarz G, Embaby MA, Doleib NM, Taha MM. Effect of dietary antioxidant supplementation (Cuminum cyminum) on bacterial susceptibility of diabetes-induced rats. Cent Eur J Immunol. 2016;41(2):132-7. doi: 10.5114/ceji.2016.60985. Epub 2016 Jul 15. PMID: 27536197; PMCID: PMC4967646.
Copy Download .nbib Format: NLM
A rare case of Addison's disease, hepatitis, thyreoiditis, positive IgG anti-tissue transglutaminase antibodies and partial IgA deficiency.

Central-European journal of immunology

Baleva MP, Mihaylova S, Yankova P, Atanasova I, Nikolova-Vlahova M, Naumova E.
PMID: 27536208
Cent Eur J Immunol. 2016;41(2):217-20. doi: 10.5114/ceji.2016.60997. Epub 2016 Jul 15.

INTRODUCTION: Selective IgA deficiency (IgAD) is the most prevalent type of primary immune deficiencies, but partial IgA deficiency is even more common. Addison's disease is a rare condition associated with primary adrenal insufficiency due to infection or autoimmune destruction...

Cite
Baleva MP, Mihaylova S, Yankova P, et al. A rare case of Addison's disease, hepatitis, thyreoiditis, positive IgG anti-tissue transglutaminase antibodies and partial IgA deficiency. Cent Eur J Immunol. 2016;41(2):217-20doi: 10.5114/ceji.2016.60997.
Baleva, M. P., Mihaylova, S., Yankova, P., Atanasova, I., Nikolova-Vlahova, M., & Naumova, E. (2016). A rare case of Addison's disease, hepatitis, thyreoiditis, positive IgG anti-tissue transglutaminase antibodies and partial IgA deficiency. Central-European journal of immunology, 41(2), 217-20. https://doi.org/10.5114/ceji.2016.60997
Baleva, Marta P, et al. "A rare case of Addison's disease, hepatitis, thyreoiditis, positive IgG anti-tissue transglutaminase antibodies and partial IgA deficiency." Central-European journal of immunology vol. 41,2 (2016): 217-20. doi: https://doi.org/10.5114/ceji.2016.60997
Baleva MP, Mihaylova S, Yankova P, Atanasova I, Nikolova-Vlahova M, Naumova E. A rare case of Addison's disease, hepatitis, thyreoiditis, positive IgG anti-tissue transglutaminase antibodies and partial IgA deficiency. Cent Eur J Immunol. 2016;41(2):217-20. doi: 10.5114/ceji.2016.60997. Epub 2016 Jul 15. PMID: 27536208; PMCID: PMC4967656.
Copy Download .nbib Format: NLM
CD4(+)CD25(+) regulatory T cells as a therapeutic target in rheumatoid arthritis.

Central-European journal of immunology

Yu Q, Xu M, Yu F, Jin Y.
PMID: 26155108
Cent Eur J Immunol. 2014;39(1):100-3. doi: 10.5114/ceji.2014.42133. Epub 2014 Apr 17.

CD4(+)CD25(+) T cells are regulatory T cells (CD4(+)CD25(+) Tregs), which can strengthen immune tolerance. They play a critical role in controlling the development of autoimmune diseases in animals and humans. Rheumatoid arthritis (RA) is a chronic autoimmune disease that...

Cite
Yu Q, Xu M, Yu F, et al. CD4(+)CD25(+) regulatory T cells as a therapeutic target in rheumatoid arthritis. Cent Eur J Immunol. 2014;39(1):100-3doi: 10.5114/ceji.2014.42133.
Yu, Q., Xu, M., Yu, F., & Jin, Y. (2014). CD4(+)CD25(+) regulatory T cells as a therapeutic target in rheumatoid arthritis. Central-European journal of immunology, 39(1), 100-3. https://doi.org/10.5114/ceji.2014.42133
Yu, Qing, et al. "CD4(+)CD25(+) regulatory T cells as a therapeutic target in rheumatoid arthritis." Central-European journal of immunology vol. 39,1 (2014): 100-3. doi: https://doi.org/10.5114/ceji.2014.42133
Yu Q, Xu M, Yu F, Jin Y. CD4(+)CD25(+) regulatory T cells as a therapeutic target in rheumatoid arthritis. Cent Eur J Immunol. 2014;39(1):100-3. doi: 10.5114/ceji.2014.42133. Epub 2014 Apr 17. PMID: 26155108; PMCID: PMC4439972.
Copy Download .nbib Format: NLM
The effect of interleukin 17 and Toll-like receptor 2 on CD11b expression and apoptosis of neutrophils in zymosaninduced arthritis and paw oedema.

Central-European journal of immunology

Milanova V, Ivanovska N, Dimitrova P.
PMID: 26155114
Cent Eur J Immunol. 2014;39(2):131-41. doi: 10.5114/ceji.2014.43712. Epub 2014 Jun 27.

We investigated the effect of interleukin (IL)-17 on Ly6G(+) cell apoptosis in zymosan-induced arthritis (ZIA) and oedema (ZIO). Zymosan injection at the ankle joint caused swelling and coincided with histological joint alterations and IL-17A expression in areas with cell...

Cite
Milanova V, Ivanovska N, Dimitrova P. The effect of interleukin 17 and Toll-like receptor 2 on CD11b expression and apoptosis of neutrophils in zymosaninduced arthritis and paw oedema. Cent Eur J Immunol. 2014;39(2):131-41doi: 10.5114/ceji.2014.43712.
Milanova, V., Ivanovska, N., & Dimitrova, P. (2014). The effect of interleukin 17 and Toll-like receptor 2 on CD11b expression and apoptosis of neutrophils in zymosaninduced arthritis and paw oedema. Central-European journal of immunology, 39(2), 131-41. https://doi.org/10.5114/ceji.2014.43712
Milanova, Viktoriya, et al. "The effect of interleukin 17 and Toll-like receptor 2 on CD11b expression and apoptosis of neutrophils in zymosaninduced arthritis and paw oedema." Central-European journal of immunology vol. 39,2 (2014): 131-41. doi: https://doi.org/10.5114/ceji.2014.43712
Milanova V, Ivanovska N, Dimitrova P. The effect of interleukin 17 and Toll-like receptor 2 on CD11b expression and apoptosis of neutrophils in zymosaninduced arthritis and paw oedema. Cent Eur J Immunol. 2014;39(2):131-41. doi: 10.5114/ceji.2014.43712. Epub 2014 Jun 27. PMID: 26155114; PMCID: PMC4440028.
Copy Download .nbib Format: NLM
Effects of the recombinant allergen rDer f 2 on neuro-endocrino-immune network in asthmatic mice.

Central-European journal of immunology

Jiang YQ, Zhou ZX, Ji YL.
PMID: 26155138
Cent Eur J Immunol. 2014;39(3):294-8. doi: 10.5114/ceji.2014.45938. Epub 2014 Oct 14.

Severe and life-threatening side effects can occur in patients receiving allergen-specific immunotherapy (SIT), and recombinant allergens made from cDNA have been used in clinical trials for ten years and appear promising for SIT. The aim of this study is...

Cite
Jiang YQ, Zhou ZX, Ji YL. Effects of the recombinant allergen rDer f 2 on neuro-endocrino-immune network in asthmatic mice. Cent Eur J Immunol. 2014;39(3):294-8doi: 10.5114/ceji.2014.45938.
Jiang, Y. Q., Zhou, Z. X., & Ji, Y. L. (2014). Effects of the recombinant allergen rDer f 2 on neuro-endocrino-immune network in asthmatic mice. Central-European journal of immunology, 39(3), 294-8. https://doi.org/10.5114/ceji.2014.45938
Jiang, Yong-Qian, et al. "Effects of the recombinant allergen rDer f 2 on neuro-endocrino-immune network in asthmatic mice." Central-European journal of immunology vol. 39,3 (2014): 294-8. doi: https://doi.org/10.5114/ceji.2014.45938
Jiang YQ, Zhou ZX, Ji YL. Effects of the recombinant allergen rDer f 2 on neuro-endocrino-immune network in asthmatic mice. Cent Eur J Immunol. 2014;39(3):294-8. doi: 10.5114/ceji.2014.45938. Epub 2014 Oct 14. PMID: 26155138; PMCID: PMC4440009.
Copy Download .nbib Format: NLM
Effects of sufentanil on human gastric cancer cell line SGC-7901 in vitro.

Central-European journal of immunology

Wu W, Wei N, Jiang CN, Cui S, Yuan J.
PMID: 26155139
Cent Eur J Immunol. 2014;39(3):299-305. doi: 10.5114/ceji.2014.45939. Epub 2014 Oct 14.

Sufentanil is a new kind of opioid analgesic and acts on μ opioid receptor. In this study, we aim to investigate the effects of sufentanil on gastric cancer cell line SGC-7901, after being exposed to different concentrations of sufentanil....

Cite
Wu W, Wei N, Jiang CN, et al. Effects of sufentanil on human gastric cancer cell line SGC-7901 in vitro. Cent Eur J Immunol. 2014;39(3):299-305doi: 10.5114/ceji.2014.45939.
Wu, W., Wei, N., Jiang, C. N., Cui, S., & Yuan, J. (2014). Effects of sufentanil on human gastric cancer cell line SGC-7901 in vitro. Central-European journal of immunology, 39(3), 299-305. https://doi.org/10.5114/ceji.2014.45939
Wu, Weidong, et al. "Effects of sufentanil on human gastric cancer cell line SGC-7901 in vitro." Central-European journal of immunology vol. 39,3 (2014): 299-305. doi: https://doi.org/10.5114/ceji.2014.45939
Wu W, Wei N, Jiang CN, Cui S, Yuan J. Effects of sufentanil on human gastric cancer cell line SGC-7901 in vitro. Cent Eur J Immunol. 2014;39(3):299-305. doi: 10.5114/ceji.2014.45939. Epub 2014 Oct 14. PMID: 26155139; PMCID: PMC4440010.
Copy Download .nbib Format: NLM
Application of flow cytometry in diagnosing lymphomas in dogs and cats.

Central-European journal of immunology

Aniołek O, Gajewski Z, Giziński S.
PMID: 26155143
Cent Eur J Immunol. 2014;39(3):327-30. doi: 10.5114/ceji.2014.45943. Epub 2014 Oct 14.

Classification of types of lymphomas is done by interpreting cell morphology results obtained in cytological and/or histological examinations. In recent years, additional methods like immunocytochemistry (ICC), immunohistochemistry (IHC), immunophenotyping by flow cytometry and polymerase chain reaction (PCR) for antigen...

Cite
Aniołek O, Gajewski Z, Giziński S. Application of flow cytometry in diagnosing lymphomas in dogs and cats. Cent Eur J Immunol. 2014;39(3):327-30doi: 10.5114/ceji.2014.45943.
Aniołek, O., Gajewski, Z., & Giziński, S. (2014). Application of flow cytometry in diagnosing lymphomas in dogs and cats. Central-European journal of immunology, 39(3), 327-30. https://doi.org/10.5114/ceji.2014.45943
Aniołek, Olga, et al. "Application of flow cytometry in diagnosing lymphomas in dogs and cats." Central-European journal of immunology vol. 39,3 (2014): 327-30. doi: https://doi.org/10.5114/ceji.2014.45943
Aniołek O, Gajewski Z, Giziński S. Application of flow cytometry in diagnosing lymphomas in dogs and cats. Cent Eur J Immunol. 2014;39(3):327-30. doi: 10.5114/ceji.2014.45943. Epub 2014 Oct 14. PMID: 26155143; PMCID: PMC4440007.
Copy Download .nbib Format: NLM
CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients.

Central-European journal of immunology

Biylgi O, Karagöz B, Türken O, Gültepe M, Özgün A, Tunçel T, Emirzeoğlu L, Çelik S, Müftüoğlu T, Gökhan Kandemir E.
PMID: 26155145
Cent Eur J Immunol. 2014;39(3):338-44. doi: 10.5114/ceji.2014.45945. Epub 2014 Oct 14.

AIM OF THE STUDY: To investigate the percentage of CD4+CD25(high) cells (including Treg cells) and CD8+CD28- cells in breast cancer patients with and without high levels of autoimmune thyroid antibodies.MATERIAL AND METHODS: Thirty-five women with breast cancer (9 of...

Cite
Biylgi O, Karagöz B, Türken O, et al. CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients. Cent Eur J Immunol. 2014;39(3):338-44doi: 10.5114/ceji.2014.45945.
Biylgi, O., Karagöz, B., Türken, O., Gültepe, M., Özgün, A., Tunçel, T., Emirzeoğlu, L., Çelik, S., Müftüoğlu, T., & Gökhan Kandemir, E. (2014). CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients. Central-European journal of immunology, 39(3), 338-44. https://doi.org/10.5114/ceji.2014.45945
Biylgi, Oğuz, et al. "CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients." Central-European journal of immunology vol. 39,3 (2014): 338-44. doi: https://doi.org/10.5114/ceji.2014.45945
Biylgi O, Karagöz B, Türken O, Gültepe M, Özgün A, Tunçel T, Emirzeoğlu L, Çelik S, Müftüoğlu T, Gökhan Kandemir E. CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients. Cent Eur J Immunol. 2014;39(3):338-44. doi: 10.5114/ceji.2014.45945. Epub 2014 Oct 14. PMID: 26155145; PMCID: PMC4439998.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 776 entries